AHI1

Across TCGA pan-cancer cohorts, AHI1 Mutation is linked to patient survival in 7 of 34 cancer types, making it a survival-associated AHI1 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher AHI1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated AHI1 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

ESCA, COAD, and THCA are the cancer types where AHI1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.074	0.703	<.001	48	view →
COAD	DFS	Median	All	0.205	0.698	.027	7	view →
THCA	OS	Median	All	0.277	0.954	<.001	6	view →
PRAD	DFS	Median	All	0.617	0.886	.041	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
BLCA	DFS	Median	II,III,IV	1.000	0.608	.040	4	view →
LUAD	DFS	Median	All	0.633	0.814	.037	2	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

AHI1–ESCA (OS)

Open the ESCA breakdown →